ModelEdge

InMed Pharmaceuticals Inc.
INM
Filing TypeS-3
Filing Date3/19/2026
Updated3/20/26, 3:00 PM

Filing

S-3
Earnings Release

Exhibits

S-3Registration Statement for Securities Offered under a Shelf Registration
EX-5.1OPINION OF NORTON ROSE FULBRIGHT CANADA LLP REGARDING LEGALITY OF SECURITIES BEING REGISTERED
EX-23.1CONSENT OF CBIZ CPAS P.C., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-23.2CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-FILING FEESFILING FEE TABLE
GRAPHICGraphic
GRAPHICGraphic